New mechanisms involved in the pathogenesis of pituitary adenomas.

被引:0
|
作者
Giacomini, D
Paez-Pereda, M
Refojo, D
Nagashima, AC
Chervin, A
Goldberg, V
Arzt, E
机构
[1] Univ Buenos Aires, Dept Fisiol & Biol Celular & Mol, FCEN, RA-1428 Buenos Aires, DF, Argentina
[2] Hosp Santa Lucia, Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Fac Med, Inst Invest Med Alfredo Lanari, RA-1428 Buenos Aires, DF, Argentina
关键词
prolactinoma; c-Myc;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
New mechanisms involved in the pathogenesis of pituitary adenomas. We studied Smad-4dn tumors generated from lactosomatotrophic GH3 cells stably transfected with a dominant negative form of Smad-4 (a bone morphogenetic protein-4, BMP-4, signal co-transducer) which had reduced tumorigenicity in nude mice, but had showed a late increase in tumor size. We found that they had lost in vivo the expression of Smad-4dn and had recovered c-Myc expression. In accordance, BMP-4 is overexpressed and stimulates the expression of c-Myc in human prolactinomas, but not in other human pituitary adenomas or normal pituitary. In adittion ICI 182,780 inhibited BMP-4 stimulated c-Myc expression and BMP-4 and 17beta-estradiol in combination had an additive effect on GH3 cell proliferation. Their action was inhibited by blocking BMP-4 with ICI 182,780 or 117beta-estradiol with Smad-4dn. Furthermore, co-immunoprecipitation studies demonstrate that Smad-4 physically interacts with the ERalpha/ERbeta. We show for the first time the role of BMP-4 in prolactinoma pathogenesis, involving a functional cross-talk BMP-4/E2.
引用
收藏
页码:147 / 150
页数:4
相关论文
共 50 条
  • [41] NEURO-OPHTHALMOLOGICAL MANIFESTATIONS OF PITUITARY ADENOMAS. THE USEFULNESS OF OPTICAL COHERENCE TOMOGRAPHY
    Ortiz-Perez, S.
    Sanchez-Dalmau, B. F.
    Molina-Fernandez, J. J.
    Adan-Civera, A.
    REVISTA DE NEUROLOGIA, 2009, 48 (02) : 85 - 90
  • [42] Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment
    Naoko Sanno
    Akira Teramoto
    R. Yoshiyuki Osamura
    Journal of Neuro-Oncology, 2001, 54 : 179 - 186
  • [43] MAP-2 expression in the human adenohypophysis and in pituitary adenomas. An immunohistochemical study
    Rotondo F.
    Oniya K.
    Kovacs K.
    Bell C.D.
    Scheithauer B.W.
    Pituitary, 2005, 8 (2) : 75 - 79
  • [44] Sclerous surprenalism with adenomas.
    Sezary, A
    COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES, 1911, 70 : 743 - 744
  • [45] Immunocytochemical localization of macrophage migration inhibitory factor in human hypophyses and pituitary adenomas.
    TampanaruSarmesiu, A
    Stefaneanu, L
    Kovacs, K
    Donelly, T
    Metz, CN
    Bucala, R
    FASEB JOURNAL, 1996, 10 (06): : 845 - 845
  • [46] Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment
    Sanno, N
    Teramoto, A
    Osamura, RY
    JOURNAL OF NEURO-ONCOLOGY, 2001, 54 (02) : 179 - 186
  • [47] Immunostaining of serrated adenomas.
    Saroufeem, R
    Tesluk, H
    Min, BU
    Ruebner, B
    Lawson, M
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (04) : 638 - 638
  • [48] CLASSIFICATION AND PATHOGENESIS OF PITUITARY ADENOMAS OF MAN AND ANIMALS
    SAEGER, W
    FORTSCHRITTE DER MEDIZIN, 1977, 95 (22) : 1458 - 1462
  • [49] Somatic and germline mutations in the pathogenesis of pituitary adenomas
    Vandeva, Silvia
    Daly, Adrian F.
    Petrossians, Patrick
    Zacharieva, Sabina
    Beckers, Albert
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2019, 181 (06) : R235 - R254
  • [50] Pathogenesis of non-functioning pituitary adenomas
    Zatelli, Maria Chiara
    PITUITARY, 2018, 21 (02) : 130 - 137